MYC—master regulator of the cancer epigenome and transcriptome

Candace J. Poole, Jan Van Riggelen

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Overexpression of MYC is a hallmark of many human cancers. The MYC oncogene has long been thought to execute its neoplastic functions by acting as a classic transcription factor, deregulating the expression of a large number of specific target genes. However, MYC’s influence on many of these target genes is rather modest and there is little overlap between MYC regulated genes in different cell types, leaving many mechanistic questions unanswered. Recent advances in the field challenge the dogma further, revealing a role for MYC that extends beyond the traditional concept of a sequence-specific transcription factor. In this article, we review MYC’s function as a regulator of the cancer epigenome and transcriptome. We outline our current understanding of how MYC regulates chromatin structure in both a site-specific and genome-wide fashion, and highlight the implications for therapeutic strategies for cancers with high MYC expression.

Original languageEnglish (US)
Article number142
JournalGenes
Volume8
Issue number5
DOIs
StatePublished - May 13 2017

Fingerprint

Transcriptome
Transcription Factors
Genes
Neoplasms
Oncogenes
Chromatin
Genome
Therapeutics

Keywords

  • Cancer
  • Chromatin remodeling
  • MYC

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

MYC—master regulator of the cancer epigenome and transcriptome. / Poole, Candace J.; Van Riggelen, Jan.

In: Genes, Vol. 8, No. 5, 142, 13.05.2017.

Research output: Contribution to journalReview article

Poole, Candace J. ; Van Riggelen, Jan. / MYC—master regulator of the cancer epigenome and transcriptome. In: Genes. 2017 ; Vol. 8, No. 5.
@article{f8332c45e2a041cd8d6bb4d17eb64083,
title = "MYC—master regulator of the cancer epigenome and transcriptome",
abstract = "Overexpression of MYC is a hallmark of many human cancers. The MYC oncogene has long been thought to execute its neoplastic functions by acting as a classic transcription factor, deregulating the expression of a large number of specific target genes. However, MYC’s influence on many of these target genes is rather modest and there is little overlap between MYC regulated genes in different cell types, leaving many mechanistic questions unanswered. Recent advances in the field challenge the dogma further, revealing a role for MYC that extends beyond the traditional concept of a sequence-specific transcription factor. In this article, we review MYC’s function as a regulator of the cancer epigenome and transcriptome. We outline our current understanding of how MYC regulates chromatin structure in both a site-specific and genome-wide fashion, and highlight the implications for therapeutic strategies for cancers with high MYC expression.",
keywords = "Cancer, Chromatin remodeling, MYC",
author = "Poole, {Candace J.} and {Van Riggelen}, Jan",
year = "2017",
month = "5",
day = "13",
doi = "10.3390/genes8050142",
language = "English (US)",
volume = "8",
journal = "Genes",
issn = "2073-4425",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "5",

}

TY - JOUR

T1 - MYC—master regulator of the cancer epigenome and transcriptome

AU - Poole, Candace J.

AU - Van Riggelen, Jan

PY - 2017/5/13

Y1 - 2017/5/13

N2 - Overexpression of MYC is a hallmark of many human cancers. The MYC oncogene has long been thought to execute its neoplastic functions by acting as a classic transcription factor, deregulating the expression of a large number of specific target genes. However, MYC’s influence on many of these target genes is rather modest and there is little overlap between MYC regulated genes in different cell types, leaving many mechanistic questions unanswered. Recent advances in the field challenge the dogma further, revealing a role for MYC that extends beyond the traditional concept of a sequence-specific transcription factor. In this article, we review MYC’s function as a regulator of the cancer epigenome and transcriptome. We outline our current understanding of how MYC regulates chromatin structure in both a site-specific and genome-wide fashion, and highlight the implications for therapeutic strategies for cancers with high MYC expression.

AB - Overexpression of MYC is a hallmark of many human cancers. The MYC oncogene has long been thought to execute its neoplastic functions by acting as a classic transcription factor, deregulating the expression of a large number of specific target genes. However, MYC’s influence on many of these target genes is rather modest and there is little overlap between MYC regulated genes in different cell types, leaving many mechanistic questions unanswered. Recent advances in the field challenge the dogma further, revealing a role for MYC that extends beyond the traditional concept of a sequence-specific transcription factor. In this article, we review MYC’s function as a regulator of the cancer epigenome and transcriptome. We outline our current understanding of how MYC regulates chromatin structure in both a site-specific and genome-wide fashion, and highlight the implications for therapeutic strategies for cancers with high MYC expression.

KW - Cancer

KW - Chromatin remodeling

KW - MYC

UR - http://www.scopus.com/inward/record.url?scp=85019200369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019200369&partnerID=8YFLogxK

U2 - 10.3390/genes8050142

DO - 10.3390/genes8050142

M3 - Review article

VL - 8

JO - Genes

JF - Genes

SN - 2073-4425

IS - 5

M1 - 142

ER -